 |
|
Perioperative Glycemic Control and Diabetic Retinopathy—Reply
Chikako Suto, MD;
Sadao Hori, MD;
Satoshi Kato, MD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank Dr Salti and colleagues for their interest in our article1 and for noting 2 significant points.
In reply to the first question they raised, the reason for using not only fundus examination and color fundus photography but also fundus fluorescein angiography to evaluate the grade of retinopathy and maculopathy was that fundus fluorescein angiography allows for more accurate evaluation of the severity of retinopathy or maculopathy. We think that adding fundus fluorescein angiography increased the reliability of our study. Accuracy was increased further by having ophthalmologists who did not know the purpose of this study perform evaluations using both the color fundus photographs and fluorescein angiograms.
The next question concerns the difference between type 1 and type 2 DM. In Japan, more than 95% of patients with DM have type 2 DM at present. According to the . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED LETTER
Perioperative Glycemic Control and Diabetic Retinopathy
Haytham I. S. Salti, Johnny K. Khoury, and Sandra Haddad
Arch Ophthalmol. 2007;125(4):577-578.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Effect of Perioperative Glycemic Control in Progression of Diabetic Retinopathy and Maculopathy
Chikako Suto, Sadao Hori, Satoshi Kato, Kanemitsu Muraoka, and Shigehiko Kitano
Arch Ophthalmol. 2006;124(1):38-45.
ABSTRACT
| FULL TEXT
Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group
Arch Ophthalmol. 1998;116(7):874-886.
ABSTRACT
| FULL TEXT
|
